These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19463449)

  • 21. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
    Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
    Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease.
    De Luca L; Altamura L; Corvo P; De Persio G; Ghini AS; Petrolini A; Aurigemma C; Tomai F
    Catheter Cardiovasc Interv; 2011 May; 77(6):765-72. PubMed ID: 21413124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term clinical outcomes with the use of a modified provisional jailed-balloon stenting technique for the treatment of nonleft main coronary bifurcation lesions.
    Depta JP; Patel Y; Patel JS; Novak E; Yeung M; Zajarias A; Kurz HI; Lasala JM; Bach RG; Singh J
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):E637-46. PubMed ID: 23420654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.
    Head SJ; Holmes DR; Mack MJ; Serruys PW; Mohr FW; Morice MC; Colombo A; Kappetein AP;
    JACC Cardiovasc Interv; 2012 Jun; 5(6):618-25. PubMed ID: 22721656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative analysis of major clinical outcomes using drug-eluting stents versus bare metal stents in diabetic versus nondiabetic patients.
    Minha S; Bental T; Assali A; Vaknin-Assa H; Lev EI; Rechavia E; Battler A; Kornowski R
    Catheter Cardiovasc Interv; 2011 Nov; 78(5):710-7. PubMed ID: 21805561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents.
    Singh M; Lennon RJ; Darbar D; Gersh BJ; Holmes DR; Rihal CS
    Mayo Clin Proc; 2004 Sep; 79(9):1113-8. PubMed ID: 15357032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial.
    Montalescot G; Gallo R; White HD; Cohen M; Steg PG; Aylward PE; Bode C; Chiariello M; King SB; Harrington RA; Desmet WJ; Macaya C; Steinhubl SR;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1083-91. PubMed ID: 19926048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Periprocedural myocardial infarction is not associated with an increased risk of long-term cardiac mortality after coronary bifurcation stenting.
    Song PS; Song YB; Yang JH; Kang GH; Hahn JY; Choi SH; Choi JH; Lee SH; Jang Y; Yoon JH; Tahk SJ; Seung KB; Park SJ; Gwon HC
    Int J Cardiol; 2013 Aug; 167(4):1251-6. PubMed ID: 22494861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of percutaneous coronary interventions performed at centers without and with onsite coronary artery bypass graft surgery.
    Wennberg DE; Lucas FL; Siewers AE; Kellett MA; Malenka DJ
    JAMA; 2004 Oct; 292(16):1961-8. PubMed ID: 15507581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Everolimus-eluting stents and zotarolimus-eluting stents for percutaneous coronary interventions: two-year outcomes in New York State.
    Hannan EL; Zhong Y; Wu C; Walford G; Holmes DR; Jacobs AK; Stamato NJ; Venditti FJ; Sharma S; Fergus I; King SB
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1097-105. PubMed ID: 22707353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of diabetes mellitus on the practice and outcomes of percutaneous coronary intervention in the community: a report from the HCA database.
    Kugelmass AD; Cohen DJ; Houser F; Mack M; Simon AW; Battaglia SL; Tarkington LG; Becker ER; Culler SD
    J Invasive Cardiol; 2003 Oct; 15(10):568-74. PubMed ID: 14519889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome of stents versus bypass surgery in diabetic and nondiabetic patients with multivessel or left main coronary artery disease: a pooled analysis of 5775 individual patient data.
    Park DW; Kim YH; Song HG; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Chung SH; Choo SJ; Chung CH; Lee JW; Park SJ
    Circ Cardiovasc Interv; 2012 Aug; 5(4):467-75. PubMed ID: 22872052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of cardiac catheterization and percutaneous coronary intervention for in-hospital ventricular tachycardia or fibrillation cardiac arrest.
    Helton TJ; Nadig V; Subramanya SD; Menon V; Ellis SG; Shishehbor MH
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):E9-14. PubMed ID: 21735517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of drug-eluting stents for protected left main coronary artery disease (from the Multicenter, United States DEScover registry).
    Leitner J; Vlachos HA; Selzer F; Jamal SM; Kip KE; Williams DO; Abbott JD
    Am J Cardiol; 2012 Feb; 109(4):466-70. PubMed ID: 22118825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transradial versus transfemoral method of percutaneous coronary revascularization for unprotected left main coronary artery disease: comparison of procedural and late-term outcomes.
    Yang YJ; Kandzari DE; Gao Z; Xu B; Chen JL; Qiao SB; Li JJ; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; Liu HB; Dai J; Chen T; Wang Y; Li W; Gao RL
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1035-42. PubMed ID: 20965462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival benefit with concomitant clopidogrel and glycoprotein IIb/IIIa inhibitor therapy at ad hoc percutaneous coronary intervention.
    Gumina RJ; Yang EH; Sandhu GS; Prasad A; Bresnahan JF; Lennon RJ; Rihal CS; Holmes DR; Singh M
    Mayo Clin Proc; 2008 Sep; 83(9):995-1001. PubMed ID: 18775199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical outcomes of percutaneous coronary intervention performed without pre-procedural aspirin.
    Kenaan M; Seth M; Aronow HD; Wohns D; Share D; Gurm HS;
    J Am Coll Cardiol; 2013 Dec; 62(22):2083-9. PubMed ID: 24055844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes of coronary-artery bypass grafting versus stent implantation.
    Hannan EL; Racz MJ; Walford G; Jones RH; Ryan TJ; Bennett E; Culliford AT; Isom OW; Gold JP; Rose EA
    N Engl J Med; 2005 May; 352(21):2174-83. PubMed ID: 15917382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary revascularization in patients with small-vessel disease.
    Puymirat E; Peace A; Mangiacapra F; Conte M; Ntarladimas Y; Bartunek J; Vanderheyden M; Wijns W; De Bruyne B; Barbato E
    Circ Cardiovasc Interv; 2012 Feb; 5(1):62-8. PubMed ID: 22319067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.